Yoshitaka Sekido

9PUBLICATIONS
44CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMedical infection agents (incl. prions)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 02, 2026
BAP1 and USP1 cooperate to regulate FANCD2 stability and cell proliferation in mesothelioma cells.

|Mar 06, 2026
Enhanced nuclear export caused by O-GlcNAcylation of nucleoporins is a potential therapeutic target in mesothelioma.

Satomi Mukai, Tatsuhiro Sato, Yasuhiro Kamei

|Aug 07, 2025
Pleural mesothelioma.

Dean A Fennell, Yoshitaka Sekido, Paul Baas

|Dec 17, 2024
TEAD-Independent Cell Growth of Hippo-Inactive Mesothelioma Cells: Unveiling Resistance to TEAD Inhibitor K-975 through MYC Signaling Activation.

Ken Akao, Tatsuhiro Sato, Emi Mishiro-Sato

|Oct 06, 2023
Effects of Combined Therapeutic Targeting of AXL and ATR on Pleural Mesothelioma Cells.

Soichi Hirai, Tadaaki Yamada, Yuki Katayama

|Nov 06, 2022
SMG6 regulates DNA damage and cell survival in Hippo pathway kinase LATS2-inactivated malignant mesothelioma.

Koya Suzuki, Masaki Tange, Ryota Yamagishi

Pageof 2

Frequent Collaborators

2 joint publications

Yuko Murakami-Tonami

2 joint publications

Satomi Mukai

2 joint publications

Emi Mishiro-Sato

2 joint publications

Tatsuhiro Sato